Corporate Finance

Blue Owl's OBDC II faces a discounted activist bid, countering with a massive capital return plan. Shareholders must choose: cheap cash now or full value later?

Dr. Mark Newman earns the prestigious John von Neumann Prize for his foundational work in network science, the hidden math shaping our connected world.

A new report reveals a puzzling slowdown in CLO issuance despite low credit yields. Experts analyze the hidden headwinds and shifting investor strategies.

Amid rising avian flu concerns, Canada secures millions of next-gen cell-based vaccines, upgrading its pandemic response arsenal for faster protection.

The fast-growing beauty brand founded by Halsey partners with Barrett Distribution Centers to scale its omnichannel operations from a strategic Memphis hub.

After driving Hyosung Americas to #1 in the market with double-digit growth, veteran COO Nancy Gail Daniels announces her departure. What's next?

Eli Lilly and the WHO Foundation have launched a new collaboration to strengthen health systems and combat the escalating obesity crisis in underserved regions.

Raising over $600k with CAF, recovery tech brand FIT KING makes a strategic push into adaptive sports, aiming to redefine performance and accessibility.

With lawyers facing sanctions for AI errors, Advocacy has launched a 'case memory' platform with $3.5M in funding to deliver flawless legal context.

Newrez has again swept Fannie Mae's top honors. Discover how its focus on AI and customer service sets new industry standards for millions of homeowners.

A new nicotine-free pouch powered by a caffeine metabolite enters the market, led by a controversial founder aiming to redefine focus and energy.

As the BNP Paribas Open unfolds, every point is a victory for young girls, funding a program that has spent 30 years building confidence and character.

A landmark court decision certifies a massive class action against Johnson & Johnson, alleging its Baby Powder caused cancer and the company misled consumers.

With key investor conferences ahead, Fiserv's leadership must convince Wall Street its costly strategic investments will pay off amid slowing growth.

Newcomer Kavayn aims to disrupt the booming kava industry by combining direct farmer financing in the Pacific with high-potency CO2 extraction methods.

Virtual care leader Salvo Health gains a key edge with exclusive access to a unique home ECG device, aiming to transform outcomes for millions with GI issues.

Amid a volatile year and mounting debt, Century Casinos' upcoming Q4 results will be a critical test. Investors await news on a strategic review.

Tiptree Inc. is selling its largest businesses for over $1.1B, boosting book value but facing market skepticism as it forges a new path as a capital allocator.

With $10M in fresh funding led by Asymmetric Capital, Voomi Supply is using AI to overhaul the fragmented, multi-trillion dollar industrial parts industry.

GoodRx's new program with Eli Lilly provides Zepbound at a fixed price for employers, signaling a major shift in business strategy and raising new questions about equity.